- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes A CE/CME Supplement to The American Journal of Managed Care
3.0 Credits - CME/CPE | Expires 12/15/2015
The activity is supported by educational grants from AbbVie Inc, Astellas Scientific and Medical Affairs, Inc, and Janssen Biotech, Inc., and administered by Janssen Scientific Affairs, LLC, and sanofi-aventis US.
Faculty
Robert Dreicer, MD, MS, FACP, FASCO
Director, GU Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Deputy Associate Director of Clinical Research
Case Comprehensive Cancer Center
Cleveland, Ohio
Michael Kolodziej, MD, FACP
National Medical Director
Oncology Solutions
Aetna
Hartford, Connecticut
Neal Shore, MD, FACS
Medical Director
Carolina Urologic Research Center (CURC)
Atlantic Urology Clinics
Myrtle Beach, South Carolina
Activity Overview
Prostate cancer is the most common cancer and the second-leading cause of death among men in the United States. It is associated with significant clinical and economic burden. This supplement is intended to provide a clinical understanding of prostate cancer, discuss current, new, and evolving treatment strategies for early-stage, recurrent, and advanced prostate cancer, and discuss the economic burden of the disease.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Summarize the overall cost-effectiveness of treatment strategies for early-stage prostate cancer
- Ascertain the currently available and investigative treatment options for patients with biochemically recurrent prostate cancer
- Discuss the rapidly evolving treatment landscape for advanced prostate cancer and the role of new agents
Intended Audience
Managed care clinicians and administrators, including physicians, pharmacists, medical and formulary directors, and other managed care professionals involved in the care of patients with prostate cancer.
Release date: December 15, 2014
Expiration date: December 15, 2015
Estimated time to complete activity: 3.0 hours
Type of activity: Knowledge
Fee: Free
Physician Credit
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita­ tion Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The University of Cincinnati designates this journal-based activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Credit
Accreditation Statement
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number UAN 0290-9999-14-108-H01-P. The activity is available for CE credit through December 15, 2015.
Obtaining Credit:
Participants must take the pretest, read the journal supplement, and complete the online posttest achieving a passing score of 70% or higher. Once the posttest is submitted each participate will need to complete and submit the online activity evaluation and request their credit before the activity expires on December 15, 2015.
For Physician credit (CME) only
For Pharmacy credit (CPE) only
System Requirements
PC-based participants
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based participants
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: ceinfo@pharmacytimes.com.
Privacy Policy and Terms of Use Information: www.pharmacytimes.com/terms_condition.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
